Alkermes patents expiration
1. Vivitrol patents expiration
VIVITROL Litigations
| Drug Patent Number | Company | Drug Patent Title | Drug Patent Expiry | Activity Alert |
|---|---|---|---|---|
| These drug patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc). | ||||
| US6403114 | ALKERMES | Preparation of biodegradable, biocompatible microparticles containing a biologically active agent |
May, 2017
(6 years ago) | |
| US5916598 | ALKERMES | Preparation of biodegradable, biocompatible microparticles containing a biologically active agent |
May, 2017
(6 years ago) | |
| US5792477 | ALKERMES | Preparation of extended shelf-life biodegradable, biocompatible microparticles containing a biologically active agent |
May, 2017
(6 years ago) | |
| US6194006 | ALKERMES | Preparation of microparticles having a selected release profile |
Dec, 2018
(5 years ago) | |
| US6379703 | ALKERMES | Preparation of microparticles having a selected release profile |
Dec, 2018
(5 years ago) | |
| US6596316 | ALKERMES | Preparation of microparticles having a selected release profile |
Dec, 2018
(5 years ago) | |
| US6395304 | ALKERMES | Apparatus and method for preparing microparticles |
Nov, 2019
(4 years ago) | |
| US6495166 | ALKERMES | Apparatus and method for preparing microparticles using in-line solvent extraction |
Nov, 2019
(4 years ago) | |
| US6939033 | ALKERMES | Method and apparatus for preparing microparticles using in-line solvent extraction |
Nov, 2019
(4 years ago) | |
| US6537586 | ALKERMES | Apparatus and method for preparing microparticles |
Nov, 2019
(4 years ago) | |
| US6713090 | ALKERMES | Apparatus and method for preparing microparticles |
Nov, 2019
(4 years ago) | |
| US6331317 | ALKERMES | Apparatus and method for preparing microparticles |
Nov, 2019
(4 years ago) | |
| US6264987 | ALKERMES | Method for preparing microparticles having a selected polymer molecular weight |
May, 2020
(3 years ago) | |
| US6379704 | ALKERMES | Method for preparing microparticles having a selected polymer molecular weight |
May, 2020
(3 years ago) | |
| US6534092 | ALKERMES | Method for preparing microparticles having a selected polymer molecular weight |
May, 2020
(3 years ago) | |
| US6667061 | ALKERMES | Preparation of injectable suspensions having improved injectability |
May, 2020
(3 years ago) | |
| US7799345 | ALKERMES | Preparation of injectable suspensions having improved injectability |
May, 2020
(3 years ago) | |
| US6495164 | ALKERMES | Preparation of injectable suspensions having improved injectability |
May, 2020
(3 years ago) | |
| US7919499 | ALKERMES | Naltrexone long acting formulations and methods of use |
Oct, 2029
(5 years from now) | |
| Drug Exclusivity | Drug Exclusivity Expiration |
|---|---|
| New Indication(I-631) | Oct 12, 2013 |
Drugs and Companies using NALTREXONE ingredient
Market Authorisation Date: 13 April, 2006
Treatment: Treatment of alcohol dependence
Dosage: FOR SUSPENSION, EXTENDED RELEASE;INTRAMUSCULAR
How can I launch a generic of VIVITROL before it's drug patent expiration?
More Information on Dosage
VIVITROL family patents
